Encorafenib
BRAFTOVI (encorafenib) is an oral prescription drug manufactured by Array BioPharma Inc., available as capsules in 75mg strength (50mg discontinued). Approved under NDA210496, it's used for certain cancers. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | BRAFTOVI (encorafenib) is an oral prescription drug manufactured by Array BioPharma Inc., available as capsules in 75mg strength (50mg discontinued). Approved under NDA210496, it's used for certain cancers. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Encorafenib",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Encorafenib — ANDA 210496 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210496"
}
]
|
| identifier | ANDA210496 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Encorafenib |
